UNSPSC 51101688: Suramin

This classification denotes an angiogenesis activator inhibitor with the molecular formula C51H40N6O23S6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6032D45BEM, chemically known as 1,3,5-naphthylenetrisulfonic acid, 8,8-(ureylenebis(m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino))di- but generally known as suramin, which bears US NIH Compound Identifier 5361. European Medicines Agency schedules Suramin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04651MIG.

UNSPSC 51101688 Suramin is a Commodity code that does not align with the state and local procurement activity tagged under it. The recent opportunities show no procurement of Suramin, the antiparasitic pharmaceutical referenced by the code name. Instead, the opportunities soliciting under this code span medical and first aid supplies for emergency response, naloxone and drug deactivation systems for public health, generic pharmaceuticals and over-the-counter products for state employee and institutional use, and direct-to-manufacturer prescription fulfillment programs—none of which involve Suramin specifically. The issuing bodies include a county health department (Seminole County, Florida), a city fire department (City of Tampa), a state health and human services commission (Texas HHS), and a multistate cooperative purchasing alliance (MMCAP, administered by Minnesota), indicating the code is being applied across health, emergency services, and pharmacy procurement functions that do not correspond to the Suramin classification.

The geographic spread of tagged activity spans Florida, Texas, Minnesota, and Oregon through the cooperative vehicle. Representative recent opportunities include Seminole County's IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building; the City of Tampa's IFB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, due March 13, 2026, with an estimated contract value of $700,000 and a 5 percent SLBE bid discount; Texas HHS's RFI for direct-to-manufacturer prescription program capabilities, due April 3, 2026; and MMCAP's RFP for generic multi-source pharmaceuticals and OTC products, due March 26, 2026, distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson. The mismatch between the Suramin code and the actual procurement activity suggests a classification error in how these opportunities were tagged.